Loading...
•
Dec 31, 2021
Sanara MedTech Q4 2021 Earnings Report
Announced fourth quarter and full year 2021 results.
Key Takeaways
Sanara MedTech reported record sales results in both the fourth quarter and the full year, building on the success of their Cellerate product line and executing their strategy to offer a comprehensive solution for wound and skin care in all care settings.
Built on the success of the Cellerate product line.
Executed strategy to offer a comprehensive solution for wound and skin in all care settings.
Achieved record sales results in both the fourth quarter and the full year.
Focused on providing patients with efficacious solutions that improve outcomes at a lower overall cost.
Sanara MedTech
Sanara MedTech
Forward Guidance
No specific forward guidance was provided in the press release.